CSPG4 and Hepatic fibrosis: Importantly, inhibition of NG2 by its specific siRNA alleviates liver fibrosis in MCDHF mice, as demonstrated by the decreased expression of fibrotic parameters, collagen deposition, serum transaminase levels, liver steatosis and inflammation after the administration of Cspg4 siRNA in MCDHF mice.